COVID-19: GP & LP perspectives on valuations The webinar will - PowerPoint PPT Presentation

Dec 27, 2022 •158 likes •219 views

COVID-19: GP & LP perspectives on valuations The webinar will begin shortly Please submit questions using the questions pane in the menu on the right of your screen BVCA Webinar | 05 May 2020 COVID-19: GP & LP perspectives on

COVID-19: GP & LP perspectives on valuations The webinar will begin shortly Please submit questions using the questions pane in the menu on the right of your screen BVCA Webinar | 05 May 2020
COVID-19: GP & LP perspectives on valuations Paul Cunningham Leon de Bono Geoffrey Geiger Helios Investment BVCA USS Partners and IPEV Sue Hunter Michael Mowlem Marc Puglia Frog Capital Sandaire Providence Equity BVCA Webinar | 05 May 2020
The panel Moderator Host Leon de Bono Geoffrey Geiger Assistant Director General, Head of Private Equity, BVCA USS Paul Cunningham Sue Hunter Chief Financial Officer, Non-Executive Partner, Helios Investment Partners, Frog Capital and Chairman, IPEV Marc Puglia Michael Mowlem Chief Financial Officer Managing Director, and Managing Director, Sandaire Providence Equity BVCA Webinar | 05 May 2020
COVID-19: GP & LP perspectives on valuations IPEV special Challenges Looking valuation for LPs forwards guidance Venture & Practical buyout applications differences BVCA Webinar | 05 May 2020
Join us this Thursday for COVID-19: the practicalities of the exit strategy BVCA Webinar | Thursday 7 May 2020 | 2pm Michael Moore Cheryl Potter BVCA Former BVCA Chair Gurpreet Manku Leon de Bono BVCA BVCA
Thank you Find further updates and guidance at bvca.co.uk/about-us/coronavirus-updates Find us on +44(0)20 7492 0400 / bvca@bvca.co.uk / www.bvca.co.uk

Recommend

CO COVID ID-19 19 Where are we with COVID-19? What can you tell us about the CO COVID-19 19

CO COVID ID-19 19 Where are we with COVID-19? What can you tell us about the CO COVID-19 19 vaccine ine? COVID-19 in Arizona 182,203 cases overall Confirmed and probable A person is counted once, no matter how many tests

730 views • 56 slides

What we will cover: o Review of where we are with COVID-19 o Absolute Risk from COVID-19 o COVID

COVID-19 An Occupational Health Update 29 th July 2020 Dr Munna Roy , Medical Director , Integral OH What we will cover: o Review of where we are with COVID-19 o Absolute Risk from COVID-19 o COVID Age o Shielding Pause o Risk Assessment and

495 views • 23 slides

Florida COVID-19 Cases COVID-19 Cases Hillsborough COVID-19 Cases Orange COVID-19 Cases

Florida COVID-19 Cases COVID-19 Cases Hillsborough COVID-19 Cases Orange COVID-19 Cases Duval Suspended visitation and Developed 120 ambulance Deployed Rapid mandated staff screening assessment teams to Emergency Support Teams

394 views • 12 slides

1 Steps to Take Now to Prepare for COVID-19 Stay informed about COVID-19 by monitoring o CDC

Coronavirus COVID 19 Infection Prevention & Control: Getting to the Root Cause Pamela Truscott, MSN, RN, DNS-CT, QCP, RAC-CT Senior Manager, Clinical and Regulatory Services COVID-19 Questions email - COVID19@ahca.org 1 Background

354 views • 12 slides

COVID-19 in Italy Case Fatality Rate COVID-19 in Italy COVID-19 in Tuscany n/100.000 3 2

COVID-19 in Italy Case Fatality Rate COVID-19 in Italy COVID-19 in Tuscany n/100.000 3 2 1 Florence - total: 994 (0.26 %) COVID-19 in Italy COVID-19 in Italy: Severity ID/LF-ASD 1 General Population asymptomatic to mild: 81-49%

582 views • 30 slides

COVID-19 Virginia Department of Labor and Industry ABOUT CORONAVIRUS COVID-19 COVID-19 is an

COVID-19 Virginia Department of Labor and Industry ABOUT CORONAVIRUS COVID-19 COVID-19 is an infectious disease caused by the recently found virus known as SARS-CoV-2 (or coronavirus). Before the outbreak originated in Wuhan, China on

512 views • 25 slides

NIH and CDC Protocols and Causing More COVID Deaths than COVID Alone!!! If You Have COVID: Why

NIH and CDC Protocols and Causing More COVID Deaths than COVID Alone!!! If You Have COVID: Why You Should NOT go to a HOSPITAL, and what you should ASK for if you are admitted to a hospital and have tested Positive for COVID! How to Prevent

571 views • 12 slides

The impact of Covid-19 on cleared derivatives 23 April 2020 FIA engagement on COVID-19 with a

The impact of Covid-19 on cleared derivatives 23 April 2020 FIA engagement on COVID-19 with a focus on ensuring open and orderly markets Dedicated COVID-19 webpage (www.fia.org/covid-19) set up providing daily operational and regulatory

328 views • 21 slides

Guidance for Covid-2 AKA Hospitality (for the purposes of Covid) Know your enemy!

Village/Church Halls Guidance for Covid-2 AKA Hospitality (for the purposes of Covid) Know your enemy! Encapsulated virus Longevity on surfaces - Covid cannot grow on food Moves through human interaction

346 views • 11 slides

School Reentry and Advocacy Efforts in a COVID-19 Era COVID-19 CDC Resources COVID-19: CDC

School Reentry and Advocacy Efforts in a COVID-19 Era COVID-19 CDC Resources COVID-19: CDC Resources Latest COVID-19 information : www.cdc.gov/coronavirus COVID prevention:

458 views • 16 slides

Partnership Covid Summary 1. Impact of Covid-19 The virus Covid-19 hospital admissions (at 26 th

Community Planning Partnership Covid Summary 1. Impact of Covid-19 The virus Covid-19 hospital admissions (at 26 th May) ABC had the highest rate of hospitalisation 515 per 100,000 population COVID-19 Infection Rate by Sex, Deprivation and

431 views • 26 slides

CORONAVIRUS | COVID-19 CORONAVIRUS COVID-19 WHAT YOU NEED TO KNOW The Coronavirus has made

Creating a NO HARM culture for generations to come CORONAVIRUS | COVID-19 CORONAVIRUS COVID-19 WHAT YOU NEED TO KNOW The Coronavirus has made headlines around the world over the past few weeks after it was discovered in China. COVID-19 is

168 views • 12 slides

COVID-19: Update for NPs and PAs Learning Objectives Describe what is currently known about

COVID-19: Update for NPs and PAs Learning Objectives Describe what is currently known about COVID-19 epidemiology and transmission Assess current COVID-19 diagnostic strategies Discuss evolving therapeutic approaches to COVID-19

536 views • 43 slides

COVID-19: Update for NPs and PAs Learning Objectives Describe what is currently known about

963 views • 35 slides

O P P O R T U N I T Y D A Y P R E S E N T A T I O N Q 1 / 2 0 2 0 27. 02. 2020 N W N W

O P P O R T U N I T Y D A Y P R E S E N T A T I O N Q 1 / 2 0 2 0 27. 02. 2020 N W N W AGEND GENDA 1. BEFORE COVID - JAN FEB 2020 PERFORMANCE 2. COVID PANDEMIC - COVID-19 BUSINESS ADAPTATION 3. AFTER COVID - NEW NORMAL 1

907 views • 34 slides

COVID-19: Financial Impacts and Response Planning Responding to the COVID-19 Crisis COVID-19

COVID-19: Financial Impacts and Response Planning Responding to the COVID-19 Crisis COVID-19 presents a severe, prolonged crisis for Caltrain. The agency has responded to the initial crisis by adjusting service and has secured emergency

214 views • 17 slides

COVID-19: Financial Impacts and Response Planning Responding to the COVID-19 Crisis COVID-19

303 views • 16 slides

COVID-19 PANDEMIC JOEL BLANCHARD, MD, FACEP OBJECTIVES: What is COVID-19? What is COVID-

COVID-19 PANDEMIC JOEL BLANCHARD, MD, FACEP OBJECTIVES: What is COVID-19? What is COVID- 19s effect on companies? Are federal regulations relaxing? What can companies do to help? How should I direct sick employees?

336 views • 18 slides

COVID-19 FAQ Is there a vaccine, drug or treatment for COVID-19? To date, there is no vaccine and

COVID-19 FAQ Is there a vaccine, drug or treatment for COVID-19? To date, there is no vaccine and no specific antiviral medicine to prevent or treat COVID- 2019. However, those affected should receive care to relieve symptoms. People with serious

465 views • 15 slides

FAST FACTS: Discuss the progression of COVID-19 Explain COVID-19 List CDC

6/15/20 OBJECTIVES FAST FACTS: Discuss the progression of COVID-19 Explain COVID-19 List CDC recommendations COVERING Provide resources to stay updated COVID-19 Presented by Daejahnee Erby, Rebekah Farag, & Destiny Reed,

509 views • 7 slides

COVID-19 Compliance 2 July 2020 COVID-19 Our Journey Sequence of Events From little to no

COVID-19 Compliance 2 July 2020 COVID-19 Our Journey Sequence of Events From little to no knowledge of what COVID-19 is: 13 December 2019, Chinese authorities alerted the World Health Organization of pneumonia cases in Wuhan City,

400 views • 28 slides

COVID-19: Update for NPs and PAs 1 Learning Objectives Describe what is currently known

COVID-19: Update for NPs and PAs COVID-19: Update for NPs and PAs 1 Learning Objectives Describe what is currently known about COVID-19 transmission and how to prevent it Assess current COVID-19 diagnostic strategies Discuss

980 views • 75 slides

COVID-19: Update for NPs and PAs 1 Learning Objectives Describe what is currently known

1.09k views • 74 slides

What we will do - look at what we know about COVID-19 so far in relation to prospects for herbal

What we will do - look at what we know about COVID-19 so far in relation to prospects for herbal practitioners to support their patients stages of immune involvement with COVID-19 what the risk factors for COVID-19 tell us key areas

895 views • 25 slides